Submission Details
| 510(k) Number | K032528 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 15, 2003 |
| Decision Date | September 09, 2003 |
| Days to Decision | 25 days |
| Submission Type | Special |
| Review Panel | General Hospital (HO) |
| Summary | Statement |
K032528 is an FDA 510(k) clearance for the BD ECLIPSE BIFURCATED NEEDLE, a Allergen And Vaccine Delivery Needles (Class II — Special Controls, product code SCL), submitted by Becton, Dickinson & CO (Franklin Lakes, US). The FDA issued a Cleared decision on September 9, 2003, 25 days after receiving the submission on August 15, 2003. This device falls under the General Hospital review panel. Regulated under 21 CFR 880.5570.
| 510(k) Number | K032528 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 15, 2003 |
| Decision Date | September 09, 2003 |
| Days to Decision | 25 days |
| Submission Type | Special |
| Review Panel | General Hospital (HO) |
| Summary | Statement |
| Product Code | SCL — Allergen And Vaccine Delivery Needles |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 880.5570 |
| Definition | An Allergen Delivery Needle Is A Device Intended To Percutaneously Deliver Diagnostic Allergenic Extracts For Use In Allergy Skin Tests Also Referred To As Skin Prick Tests Or Intradermal Allergy Tests. |